Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example

por Winther, Stine Braendegaard, Jørgensen, Trine Lembrecht, Pfeiffer, Per, Qvortrup, Camilla
Publicado 2016

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f...

por Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, Glimelius, Bengt, Qvortrup, Camilla, Sorbye, Halfdan, Pfeiffer, Per
Publicado 2017

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer R...

por Liposits, Gabor, Skuladottir, Halla, Ryg, Jesper, Winther, Stine Brændegaard, Möller, Sören, Hofsli, Eva, Shah, Carl-Henrik, Poulsen, Laurids Østergaard, Berglund, Åke, Qvortrup, Camilla, Osterlund, Pia, Johansen, Julia S., Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per
Publicado 2022

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

por Liposits, Gabor, Eshøj, Henrik Rode, Möller, Sören, Winther, Stine Brændegaard, Skuladottir, Halla, Ryg, Jesper, Hofsli, Eva, Shah, Carl-Henrik, Poulsen, Laurids Østergaard, Berglund, Åke, Qvortrup, Camilla, Österlund, Pia, Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per
Publicado 2021